Kelarutan dan Aktivitas Antimalaria Ko-Kristal Pirimetamin-Ibuprofen
Abstract
Keywords
References
Batisai, E., Ayamine, A., Kilinkissa, O. E. Y., & Báthori, N. B. (2014). Melting point-solubility-structure correlations in multicomponent crystals containing fumaric or adipic acid. CrystEngComm, 16(43), 9992–9998.
Chieng, N., Rades, T., & Aaltonen, J. (2011). An overview of recent studies on the analysis of pharmaceutical polymorphs. Journal of Pharmaceutical and Biomedical Analysis, 55(4), 618–644.
Darwish, S., Zeglinski, J., Krishna, G. R., Shaikh, R., Khraisheh, M., Walker, G. M., & Croker, D. M. (2018). A new 1:1 drug-drug cocrystal of theophylline and aspirin: discovery, characterization, and construction of ternary phase diagrams. Crystal Growth and Design, 18(12), 7526–7532.
Dolih, G., Fikri, A., & Rani, S. (2018). Solubility Improvement of Antimalaria Drug through Co-Crystalization with Malic Acid. 22(special issue II), 280–284.
Jones, W., Motherwell, W. D. S., & Trask, A. V. (2006). Pharmaceutical Cocrystals: An Emerging Approach to Physical Property Enhancement. MRS Bulletin, 31(11), 875–879.
Kaur, R., Cavanagh, K. L., Rodríguez-Hornedo, N., & Matzger, A. J. (2017). Multidrug cocrystal of anticonvulsants: Influence of strong intermolecular interactions on physiochemical properties. Crystal Growth and Design, 17(10), 5012–5016.
Kumar, S., & Nanda, A. (2017). Pharmaceutical Cocrystals : An Overview. Indian Journal of Pharmaceutical Sciences, 79(6), 858–871.
Legorreta-Herrera, M., Retana-Ugalde, R., Ventura-Gallegos, J. L., & Narvaez, V. (2010). Pyrimethamine induces oxidative stress in Plasmodium yoelii 17XL-infected mice: a novel immunomodulatory mechanism of action for an old antimalarial drug? Experimental Parasitology, 126(3), 381–388.
Lu, E., Rodríguez-Hornedo, N., & Suryanarayanan, R. (2008). A rapid thermal method for cocrystal screening. CrystEngComm, 10(6), 665.
Miller, L. H., Good, M. F., & Milon, G. (2017). Malaria patho-genesis. Science, 1878–1883.
Peratiwi, R. P., Alatas, F., Wahyuni, F., Sugandi, R., Ratih, H., & Hermanto, F. (2016). Pengaruh Pembentukan Ko-Kristal Pirimetamin-Asam Fumarat Terhadap Kelarutan Dan Laju Disolusinya. Kartika Jurnal Ilmiah Farmasi, 4(1), 31–36.
Peterson, D. S., Walliker, D., & Wellems, T. E. (1988). Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America, 85(23), 9114–9118.
Qiao, N., Li, M., Schlindwein, W., Malek, N., Davies, A., & Trappitt, G. (2011). Pharmaceutical cocrystals: An overview. In International Journal of Pharmaceutics (Vol. 419, Issues 1–2, pp. 1–11).
Ryley, J. F., & Peters, W. (1970). The antimalarial activity of some quinolone esters. Annals of Tropical Medicine and Parasitology, 64(2), 209–222.
Saluja, H., Mehanna, A., Panicucci, R., & Atef, E. (2016). Hydrogen bonding: Between strengthening the crystal packing and improving solubility of three haloperidol derivatives. Molecules, 21(6).
Trianggani, D. F., & Sulistiyaningsih. (2018). Artikel tinjauan: Dispersi padat. Farmaka, 16(1), 93–102.
Wang, F. Y., Zhang, Q., Zhang, Z., Gong, X., Wang, J. R., & Mei, X. (2018). Solid-state characterization and solubility enhancement of apremilast drug-drug cocrystals. CrystEngComm, 20(39), 5945–5948.
DOI: 10.30595/pharmacy.v17i2.8577
Copyright (c) 2021 PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia)
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN: 2579-910X